Cardiovascular disease
Medicine & Biotech · covered by 123 outlets this week · tracked since 2026-10-27
Press: 50 mainstream 256 specialist 156 independent outlet-days
What it is
Cardiovascular disease covers heart attacks, strokes, heart failure, rhythm disorders and the narrowing of arteries behind most of them. It is still the leading cause of death worldwide, and the modifiable drivers (blood pressure, LDL cholesterol, smoking, diabetes, inactivity) are well established. Current research is testing whether lowering inflammation adds anything on top of those, how aggressively to treat older adults, and why women are diagnosed and treated later than men.
This week · The ZEUS trial found the anti-inflammatory antibody ziltivekimab lowered inflammation markers but did not reduce cardiovascular events.
Written by the Alivewire editors from the coverage below, 4d ago. Not medical advice; how the ratings work.
Coverage